BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30613001)

  • 1. Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Cirrhosis.
    Guo C; Guo G; Zhou X; Chen Y; Han Z; Yang C; Zhao S; Su H; Lian Z; Leung PSC; Gershwin ME; Zhou X; Han Y
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1175-1182.e2. PubMed ID: 30613001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the effects of long-term outcomes of autologous peripheral blood stem cell reinfusion in patients with decompensated cirrhosis].
    Cui LN; Wang XF; Sun RQ; Deng J; Gao ZJ; Zhou XM; Guo CC; Jia G; Shang YL; Yang CM; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):279-284. PubMed ID: 35462483
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.
    Sharma M; Rao PN; Sasikala M; Kuncharam MR; Reddy C; Gokak V; Raju B; Singh JR; Nag P; Nageshwar Reddy D
    World J Gastroenterol; 2015 Jun; 21(23):7264-71. PubMed ID: 26109814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Clinic Study on Long-term Efficacy and Safety of Autologous Peripheral Blood Stem Cell Transplantation in Patients with Decompensated Hepatitis B Cirrhosis.
    Zhang X; Zheng D; He L; Li W; Zhou W; Pang Z; Huang J; Deng Q
    Altern Ther Health Med; 2024 Jan; 30(1):160-166. PubMed ID: 37773668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.
    Kim JK; Kim SJ; Kim Y; Chung YE; Park YN; Kim HO; Kim JS; Park MS; Sakaida I; Kim DY; Lee JI; Ahn SH; Lee KS; Han KH
    Cell Transplant; 2017 Jun; 26(6):1059-1066. PubMed ID: 28120743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors.
    Bradstock K; Bilmon I; Kwan J; Blyth E; Micklethwaite K; Huang G; Deren S; Byth K; Gottlieb D
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1641-5. PubMed ID: 26079442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis.
    Nakamura T; Torimura T; Iwamoto H; Kurogi J; Inoue H; Hori Y; Sumie S; Fukushima N; Sakata M; Koga H; Abe M; Ikezono Y; Hashimoto O; Ueno T; Oho K; Okamura T; Okuda S; Kawamoto A; Ii M; Asahara T; Sata M
    J Gastroenterol Hepatol; 2014 Oct; 29(10):1830-8. PubMed ID: 24731186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storage Duration of Autologous Stem Cell Preparations Has No Impact on Hematopoietic Recovery after Transplantation.
    Lisenko K; Pavel P; Kriegsmann M; Bruckner T; Hillengass J; Goldschmidt H; Witzens-Harig M; Ho AD; Wuchter P
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):684-690. PubMed ID: 28013016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study.
    Wang MF; Li YB; Gao XJ; Zhang HY; Lin S; Zhu YY
    World J Stem Cells; 2018 Oct; 10(10):138-145. PubMed ID: 30397424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI).
    Li ZQ; Zhang M; Jing YZ; Zhang WW; Liu Y; Cui LJ; Yuan L; Liu XZ; Yu X; Hu TS
    Int J Cardiol; 2007 Jan; 115(1):52-6. PubMed ID: 16822566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
    Jang JW; Choi JY; Kim YS; Yoo JJ; Woo HY; Choi SK; Jun CH; Lee CH; Sohn JH; Tak WY; Lee YR; Han KH
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1954-1963.e3. PubMed ID: 29753085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring system.
    Tian S; Guo G; Zhou X; Liu Y; Jia G; Zheng L; Cui L; Wang K; Zhang M; Sun K; Ma S; Yang C; Zhou X; Guo C; Shang Y; Han Y
    Stem Cell Res Ther; 2024 Jan; 15(1):8. PubMed ID: 38167085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood stem cell transplantation improves liver functional reserve.
    Cai T; Deng Q; Zhang S; Hu A; Gong Q; Zhang X
    Med Sci Monit; 2015 May; 21():1381-6. PubMed ID: 25970080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.
    Crippa F; Holmberg L; Carter RA; Hooper H; Marr KA; Bensinger W; Chauncey T; Corey L; Boeckh M
    Biol Blood Marrow Transplant; 2002; 8(5):281-9. PubMed ID: 12064366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
    Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
    J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis.
    Xu HW; Liu F; Li HY; Wei YG; Li B
    Surg Endosc; 2018 Feb; 32(2):712-719. PubMed ID: 28726140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.